Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preladenant for Antipsychotic-Induced Extrapyramidal Symptoms
NCT00686699Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of preladenant in extrapyramidal symptoms (EPS), sponsored by Merck & Co.. Started Jul 2006; status: terminated.
02
Drugs
preladenant
03
Conditions
extrapyramidal symptoms (EPS)
Beyond the preview
Go deeper on NCT00686699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686699.